Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial. - Cleland,J.G.; Pennell,D.J.; Ray,S.G.; Coats,A.J.; Macfarlane,P.W.; Murray,G.D.; Mule,J.D.; Vered,Z.; Lahiri,A. (Lancet, 2003)